Lisdexamfetamine dimesylate: hydrolysis, pharmacokinetics and duration of therapeutic action in children and adolescents with ADHD

被引：0
|
作者：
Haege, A. [1 ]
Dittmann, R. W. [1 ]
Pennick, M. [2 ]
Sorooshian, S. [3 ]
Ermer, J. [4 ]
Adeyi, B. [4 ]
Squires, L. [4 ]
Coghill, D. R. [5 ]
机构：
[1] Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Paediat Psychopharmacol, Mannheim, Germany
[2] Shire, Basingstoke, Hants, England
[3] Shire, Eysins, Switzerland
[4] Shire, Wayne, NJ USA
[5] Univ Dundee, Div Neurosci, Dundee, Scotland
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.7.f.009
引用
收藏
页码：S733 / S734
页数：2
相关论文
共 50 条
  • [1] LISDEXAMFETAMINE DIMESYLATE FOR PRESCHOOL CHILDREN WITH ADHD
    Childress, Ann Catherine
    Kollins, Scott H.
    Wu, James
    Robertson, Brigitte
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S165 - S166
  • [2] Effect of Lisdexamfetamine Dimesylate on Sleep in Children With ADHD
    Giblin, John M.
    Strobel, Aaron L.
    JOURNAL OF ATTENTION DISORDERS, 2011, 15 (06) : 491 - 498
  • [3] Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with ADHD: randomised withdrawal design
    Coghill, D.
    Banaschewski, T.
    Lecendreux, M.
    Johnson, M.
    Zuddas, A.
    Anderson, C.
    Civil, R.
    Lyne, A.
    Gasior, M.
    Squires, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S431 - S432
  • [4] Clinical efficacy of lisdexamfetamine dimesylate in children and adolescents with ADHD: a post-hoc analysis
    Zuddas, A.
    Banaschewski, T.
    Lecendreux, M.
    Soutullo, C.
    Johnson, M.
    Anderson, C.
    Civil, R.
    Bloomfield, R.
    Squires, L.
    Coghill, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S431 - S431
  • [5] Lisdexamfetamine Dimesylate: A Prodrug Stimulant for the Treatment of ADHD in Children and Adults
    Mattingly, Gregory
    CNS SPECTRUMS, 2010, 15 (05) : 315 - 325
  • [6] Efficacy of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with ADHD: head-to-head responder analyses
    Cardo, E.
    Coghill, D.
    Nagy, P.
    Adeyi, B.
    Anderson, C.
    Caballero, B.
    Higgins, N.
    Hodgkins, P.
    Civil, R.
    Dittmann, R. W.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S603 - S604
  • [7] Effectiveness and Duration of Effect of Open-Label Lisdexamfetamine Dimesylate in Adults With ADHD
    Adler, Lenard A.
    Lynch, Lauren R.
    Shaw, David M.
    Wallace, Samantha P.
    O'Donnell, Katherine E.
    Ciranni, Michael A.
    Briggie, Alexis M.
    Faraone, Stephen V.
    JOURNAL OF ATTENTION DISORDERS, 2017, 21 (02) : 149 - 157
  • [8] Cognitive function in children and adolescents with ADHD receiving lisdexamfetamine dimesylate in a 2-year safety study
    Banaschewski, T.
    Zuddas, A.
    Bliss, C.
    Robertson, B.
    Coghill, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S737 - S737
  • [9] Understanding the Effect Size of Lisdexamfetamine Dimesylate for Treating ADHD in Children and Adults
    Faraone, Stephen V.
    JOURNAL OF ATTENTION DISORDERS, 2012, 16 (02) : 128 - 137
  • [10] Lisdexamfetamine dimesylate (LDX) in children with ADHD after suboptimal response to methylphenidate
    Jain, R.
    Duncan, D.
    Babcock, T.
    Burtea, T.
    Dirks, B.
    Adeyi, B.
    Shaw, M.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2011, 20 (01) : S126 - S127
12345